![](/img/cover-not-exists.png)
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
Salloway, S., Sperling, R., Keren, R., Porsteinsson, A. P., van Dyck, C. H., Tariot, P. N., Gilman, S., Arnold, D., Abushakra, S., Hernandez, C., Crans, G., Liang, E., Quinn, G., Bairu, M., Pastrak, AVolume:
77
Language:
english
Journal:
Neurology
DOI:
10.1212/WNL.0b013e3182309fa5
Date:
September, 2011
File:
PDF, 1.01 MB
english, 2011